Edward Lazarus

Eddie Lazarus serves as the Chief Legal Officer at Sonos. He leads the company’s legal, corporate governance, SEC reporting, government affairs, regulatory and compliance activities.

Eddie comes to Sonos after a distinguished career as an attorney, including most recently as General Counsel and Chief Strategy Officer for Tribune Media Company from 2013 to 2019. Lazarus served as the Chief of Staff to the Chairman of the Federal Communications Commission (FCC) from June 2009 to Feb. 2012. At the FCC, he oversaw policy development and implementation, strategic planning, communications, legislative and intergovernmental affairs, and agency management. Before working at the FCC, Eddie was a partner and member of the Management Committee at the law firm Akin Gump Strauss Hauer & Feld, where he chaired the firm’s national litigation steering committee. Prior to entering private practice, Eddie served as a federal prosecutor in Los Angeles.

In addition to his career as an attorney, Eddie is the author of two highly acclaimed books: “Black Hills/White Justice: The Sioux Nation Versus the United States, 1775 to the Present” and “Closed Chambers: The Rise, Fall, and Future of the Modern Supreme Court.”

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent
Read More

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More